Kaila Bennett, Ph.D.
Senior Scientist at RootPath- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Credentials
-
Basic Life Support
Red Cross Blood Services
Experience
-
RootPath
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Senior Scientist
-
Jun 2022 - Present
-
-
-
Telis Bioscience Inc.
-
United States
-
Biotechnology Research
-
Principal Scientist
-
Oct 2021 - May 2022
-
-
-
Massachusetts General Hospital
-
United States
-
Hospitals and Health Care
-
700 & Above Employee
-
Research Team Leader 1
-
Mar 2020 - Oct 2021
-
-
-
Vivtex
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Scientist and pre-clinical drug development
-
Jan 2019 - Mar 2020
-
-
-
National Heart, Lung, and Blood Institute
-
United States
-
Research Services
-
300 - 400 Employee
-
Visiting Scientist
-
Mar 2018 - Dec 2018
-
-
-
UMC Utrecht
-
Netherlands
-
Hospitals and Health Care
-
700 & Above Employee
-
Postdoctoral Researcher
-
Feb 2015 - Feb 2018
Under the mentorship of Drs Jos van Strijp and Pieter-Jan Haas, I am exploring the intestinal microbiome secretome (metagenome) to identify novel secreted proteins with anti-inflammatory properties. The main goal of this project is to identify novel therapeutics for the treatment of various chronic inflammatory disorders. Under the mentorship of Drs Jos van Strijp and Pieter-Jan Haas, I am exploring the intestinal microbiome secretome (metagenome) to identify novel secreted proteins with anti-inflammatory properties. The main goal of this project is to identify novel therapeutics for the treatment of various chronic inflammatory disorders.
-
-
-
University of California, Riverside
-
United States
-
Higher Education
-
700 & Above Employee
-
PhD Candidate
-
Sep 2010 - 2015
Under the direction of Prof. David Lo, I studied the role that surface charge plays on dictating pathogen binding to the intestinal epithelium. I also developed a T cell independent vaccine using flagellin from Salmonella typhimurium as a vaccine scaffold. Finally, using a transgenic mouse model where neutrophils and M cells express DsRed protein, I studied the regulation of M cells, during colonic inflammation Under the direction of Prof. David Lo, I studied the role that surface charge plays on dictating pathogen binding to the intestinal epithelium. I also developed a T cell independent vaccine using flagellin from Salmonella typhimurium as a vaccine scaffold. Finally, using a transgenic mouse model where neutrophils and M cells express DsRed protein, I studied the regulation of M cells, during colonic inflammation
-
-
-
Osaka University
-
Japan
-
Higher Education
-
500 - 600 Employee
-
Visiting Fellow
-
Jun 2012 - Sep 2012
Under the direction of Prof. Keiichi Namba, and Assistant Prof. Takayuki Kato, I tried to elucidate the atomic structure of hybrid flagellin filaments by employing cryo-electron microscopy. Under the direction of Prof. Keiichi Namba, and Assistant Prof. Takayuki Kato, I tried to elucidate the atomic structure of hybrid flagellin filaments by employing cryo-electron microscopy.
-
-
-
University of California, Riverside
-
United States
-
Higher Education
-
700 & Above Employee
-
Undergraduate Research Assistant
-
Jun 2008 - Jun 2010
Under the direction of Prof. Victor Rodgers, and Prof. David Lo, I studied the surface charge of PLGA (poly lactic-co-glycolic acid) vaccine nanoparticles Under the direction of Prof. Victor Rodgers, and Prof. David Lo, I studied the surface charge of PLGA (poly lactic-co-glycolic acid) vaccine nanoparticles
-
-
Education
-
University of California, Riverside
Doctor of Philosophy (Ph.D.), Biomedical/Medical Engineering -
University of California, Riverside
Bachelor's degree, Bioengineering and Biomedical Engineering